-
3-carbamoyl-1-[(2R,4R,5R)-5-[(hydrogen phosphonatooxy)methyl]-3,4-dihydroxyoxolan-2-yl]-1λ5-pyridin-1-ylium
-
ChemBase ID:
175098
-
Molecular Formular:
C11H15N2O8P
-
Molecular Mass:
334.219161
-
Monoisotopic Mass:
334.05660208
-
SMILES and InChIs
SMILES:
[C@H]1(C([C@@H](O[C@@H]1COP(=O)([O-])O)[n+]1cc(ccc1)C(=O)N)O)O
Canonical SMILES:
OC1[C@@H](O)[C@H](O[C@H]1[n+]1cccc(c1)C(=O)N)COP(=O)(O)[O-]
InChI:
InChI=1S/C11H15N2O8P/c12-10(16)6-2-1-3-13(4-6)11-9(15)8(14)7(21-11)5-20-22(17,18)19/h1-4,7-9,11,14-15H,5H2,(H3-,12,16,17,18,19)/t7-,8+,9?,11-/m1/s1
InChIKey:
DAYLJWODMCOQEW-GQEBFOJWSA-N
-
Cite this record
CBID:175098 http://www.chembase.cn/molecule-175098.html
NAMES AND DATABASE IDS
NAMES AND DATABASE IDS
Names Database IDs
IUPAC name
|
3-carbamoyl-1-[(2R,4R,5R)-5-[(hydrogen phosphonatooxy)methyl]-3,4-dihydroxyoxolan-2-yl]-1λ5-pyridin-1-ylium
|
|
|
IUPAC Traditional name
|
3-carbamoyl-1-[(2R,4R,5R)-5-[(hydrogen phosphonatooxy)methyl]-3,4-dihydroxyoxolan-2-yl]-1λ5-pyridin-1-ylium
|
|
|
Synonyms
|
3-(Aminocarbonyl)-1-(5-O-phosphono-β-D-ribofuranosyl)pyridinium Inner Salt
|
3-Carbamoyl-1-β-D-ribofuranosylpyridinium Hydroxide, 5'-Phosphate Inner Salt
|
NMN
|
Nicotinamide Mononucleotide
|
Nicotinamide Ribonucleoside 5'-Phosphate
|
Nicotinamide Ribonucleotide
|
Nicotinamide Ribotide
|
β-D-NMN
|
β-NMN
|
β-Nicotinamide Mononucleotide
|
|
|
CAS Number
|
|
PubChem SID
|
|
PubChem CID
|
|
DATA SOURCES
DATA SOURCES
All Sources Commercial Sources Non-commercial Sources
Data Source
|
Data ID
|
Price
|
TRC
|
|
CALCULATED PROPERTIES
CALCULATED PROPERTIES
JChem
Acid pKa
|
1.2132069
|
H Acceptors
|
7
|
H Donor
|
4
|
LogD (pH = 5.5)
|
-7.492876
|
LogD (pH = 7.4)
|
-8.585161
|
Log P
|
-6.244348
|
Molar Refractivity
|
70.5857 cm3
|
Polarizability
|
28.120956 Å3
|
Polar Surface Area
|
166.25 Å2
|
Rotatable Bonds
|
5
|
Lipinski's Rule of Five
|
true
|
PROPERTIES
PROPERTIES
Safety Information
Product Information
Bioassay(PubChem)
DETAILS
DETAILS
TRC
Toronto Research Chemicals -
N407765
|
A product of the extracellular Nicotinamide phosphoribosyltransferase (eNAMPT) reaction and a key NAD+ intermediate. It ameliorates glucose intolerance by restoring NAD+ levels in HFD-induced T2D mice. It also enhances hepatic insulin sensitivity and rest |
PATENTS
PATENTS
PubChem Patent
Google Patent